Consegna specializes in reformulating existing FDA-approved drugs to create innovative long-acting injectable (LAI) medications that provide enhanced clinical and economic advantages. The company's product pipeline is centered on therapeutic areas where LAIs can deliver significant therapeutic and economic benefits, such as improving patient adherence, overcoming drug delivery challenges, and minimizing side effects.

Disease Domain	Count

Immune System Diseases	4
Neoplasms	2
Nervous System Diseases	2
Endocrinology and Metabolic Disease	1
Hemic and Lymphatic Diseases	1
Infectious Diseases	1

Top 5 Drug Type	Count

Small molecule drug	7
Synthetic peptide	1
Enzyme	1
Recombinant polypeptide	1

Top 5 Target	Count

5-HT2A receptor x D2 receptor	2
NMDA receptor(Glutamate [NMDA] receptor)	1
SSTR(Somatostatin receptor)	1
GLP-1R(Glucagon-like peptide 1 receptor)	1
BChE(Butyrylcholinesterase)	1

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 22 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Discovery

Preclinical

Other

Current Projects

Drug(Targets)	Indications	Global Highest Phase

Glatiramer Acetate	Psychotic Disorders More	Preclinical
Octreotide(Consegna Pharma) ( SSTR )	Neoplasms More	Preclinical
Quetiapine Fumarate ( 5-HT2A receptor x D2 receptor )	Psychotic Disorders More	Preclinical
Risperidone ( 5-HT2A receptor x D2 receptor )	Psychotic Disorders More	Preclinical
Ketamine Hydrochloride ( NMDA receptor )	Psychotic Disorders More	Preclinical

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

Chat with Hiro

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis